From: Voxant Newsroom on Fri, Feb 18 2011 3:09 PM

Acura Pharmaceuticals (ACUR) says King Pharmaceuticals Research and Development said its New Drug Application (NDA) for ACUROX Tablets was accepted for filing by the US Food and Drug Administration (FDA) with a Priority review classification and a Prescription Drug User Fee Act (PDUFA) date of Ju...